Praxis Precision Medicines Inc (NASDAQ:PRAX) price on Friday, July 25, rose 2.09% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $59.22.
A look at the stock’s price movement, the close in the last trading session was $58.01, moving within a range at $56.685 and $61.03. The beta value (5-Year monthly) was 2.615. Turning to its 52-week performance, $91.83 and $26.70 were the 52-week high and 52-week low respectively. Overall, PRAX moved 36.67% over the past month.
Praxis Precision Medicines Inc’s market cap currently stands at around $1.21 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Jun-05.
The average forecast suggests down to a -55.99% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 691.92k, representing a -91.91% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PRAX is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend PRAX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PRAX’s current price about 16.22% and 31.59% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 78.35, while 7-day volatility ratio is 5.86% and 6.05% in the 30-day chart. Further, Praxis Precision Medicines Inc (PRAX) has a beta value of 2.65. Analysts have given the company’s stock an average 52-week price target of $85, forecast between a low of $73 and high of $120. Looking at the price targets, the low is -23.27% off current price level while to achieve the yearly target high, price needs to move -102.63%. Nonetheless, investors will most likely welcome a -43.53% jump to $85 which is the analysts’ median price.
If we refocus on Praxis Precision Medicines Inc (NASDAQ:PRAX), historical trading data shows that trading volumes averaged 0.46 over the past 10 days and 344.51K over the past 3 months. The company’s latest data on shares outstanding shows there are 20.34 million shares.
The 10.57% of Praxis Precision Medicines Inc’s shares are in the hands of company insiders while institutional holders own 113.23% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.94 million on 2025-07-15, giving us a short ratio of 5.94. The data shows that as of 2025-07-15 short interest in Praxis Precision Medicines Inc (PRAX) stood at 955.0000000000001 of shares outstanding, with shares short rising to 1.74 million registered in 2025-06-13. Current price change has pushed the stock 1.74% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PRAX stock continues to rise going into the next quarter.
